Literature DB >> 28477692

Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status.

M R P Gascón1, J Casseb2, J Smid3, J E Vidal3, L A M Fonseca3, A Paiva4, M J Haziot3, A C Penalva de Oliveira3.   

Abstract

The main goal of this study was to investigate the presence of cognitive impairment in patients infected with HTLV-1 presenting or not TSP/HAM.
METHODS: Cross-sectional study including 104 participants: 37 asymptomatic HTLV-1 carriers, 37 patients diagnosed with TSP/HAM and 30 HTLV-1 negative control patients. Within the HTLV-1 positive group, 53 were female and 21 were male, the average age was 46 (SD=13.5) and the average schooling time was 7.7years (SD=3.3).The sociodemographic variables (genre, age and education) were compared between the three groups. The assessment tools used were: Beck Depression Inventory, Lawton's Activities of Daily Life Scale and a complete neuropsychological battery. The application of these assessment tools was carried out in blind. Both HTLV-1 asymptomatic subjects and HAM/TSP patients showed a lower performance on neuropsychological tests and higher depression scores when compared to the control group. HTLV-1 patients performed poorly in several cognitive domains, but only fluid intelligence, estimated intellectual functioning, immediate and delayed recall of visual memory and information processing speed (in the specific case of patients with TSP/HAM) reached statistical significance when compared with controls. Depression was not associated with cognitive impairment. HTLV-1 carriers presented a higher frequency of cognitive impairment than normal controls.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; HTLV-1; Neuropsychology

Mesh:

Substances:

Year:  2017        PMID: 28477692     DOI: 10.1016/j.jns.2017.04.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Cognitive screening in HTLV-1-infected people using a self-perceived memory score and auditory P300.

Authors:  Aline Rejane Rosa de Castro; Ludimila Labanca; Luciana Macedo de Resende; Marjore Rhaissa de Sousa; Rafael Teixeira Scoralick Dias; Júlia Fonseca de Morais Caporali; Denise Utsch-Gonçalves
Journal:  J Neurovirol       Date:  2022-02-15       Impact factor: 2.643

Review 2.  Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: a systematic review.

Authors:  Ana Patrícia Bastos Ferreira; Ana Dolores Firmino Santos do Nascimento; Pedro Augusto Sampaio Rocha-Filho
Journal:  J Neurovirol       Date:  2022-01-03       Impact factor: 2.643

3.  Case Report: Cognitive Impairment without Clinical Spinal Disease May Be the First Sign of HTLV-1 Neurological Alteration.

Authors:  Aline Rejane Rosa de Castro; Ludimila Labanca; Luciana Macedo de Resende; Denise Utsch-Gonçalves
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

4.  Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individuals.

Authors:  Rosangela Souza Kalil; Isabelle Vasconcellos; Carolina Rosadas; Andrea Cony; Dulcino P Lima; Cassia C Alves Gonçalves; Everton Batista; Maria Fernanda Grassi; Bernardo Galvão-Castro; Graham P Taylor; Marzia Puccioni-Sohler
Journal:  J Neurovirol       Date:  2021-02-02       Impact factor: 2.643

5.  Association between Cognitive Function and Depression with Human T-Cell Lymphotropic Virus 1 Seropositivity and Serointensity in UK Adults.

Authors:  Lance D Erickson; Dawson W Hedges; Bruce L Brown; Bradley Embley; Shawn D Gale
Journal:  Pathogens       Date:  2021-10-30

6.  Ocular vestibular evoked myogenic potential (VEMP) reveals mesencephalic HTLV-1-associated neurological disease.

Authors:  Tatiana Rocha Silva; Ludimila Labanca; Júlia Fonseca de Morais Caporali; Marco Aurélio Rocha Santos; Luciana Macedo de Resende; Rafael Teixeira Scoralick Dias; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

7.  Limitations in daily activities, risk awareness, social participation, and pain in patients with HTLV-1 using the SALSA and Participation scales.

Authors:  Cintia Yolette Urbano Pauxis Aben-Athar; Denise da Silva Pinto; Sandra Souza Lima; Izaura Maria Vieira Cayres Vallinoto; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Braz J Infect Dis       Date:  2020-09-14       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.